Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Reviews on Recent Clinical Trials|May 1, 2015
Realising the potential of adaptive development of medicinesRichard W Barker, Sarah GarnerTherapeutic Innovation & Regulatory Science|September 18, 2018
The Life Sciences Translational Challenge: The European PerspectiveRichard W Barker, Jack W ScannellPharmacoeconomics|August 19, 2021
What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UKLiz Morrell, James Buchanan, Sian Rees, et al.BMC Health Services Research|March 30, 2019
Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisalsLiz Morrell, Sarah Wordsworth, Anna Schuh, et al.BMC Health Services Research|June 2, 2018
Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisalsLiz Morrell, Sarah Wordsworth, Anna Schuh, et al.Journal of Tissue Engineering|November 11, 2014
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot studyBenjamin M Davies, Sarah Rikabi, Anna French, et al.Stem Cells Translational Medicine|February 5, 2015
Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standardsAnna French, Christopher Bravery, James Smith, et al.Stem Cells and Development|December 6, 2013
The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translationDavid A Brindley, Anna French, Jane Suh, et al.Pageof 1